Merck Reports Positive Phase 3 Results for Subcutaneous Pembrolizumab in Metastatic NSCLC

Merck known as MSD outside of the United States and Canada, announced the first data presentation from the pivotal 3475A-D77 Phase 3 trial, evaluating the ...

March 28, 2025 | Friday | News
Cytiva Expands Xcellerex X-Platform Bioreactor Portfolio to Accelerate Advanced Therapeutics

    X-platform bioreactors are designed to help navigate challenges by combining reliability, scalability, and flexibility in one solution&...

March 26, 2025 | Wednesday | News
ICP DAS-BMP Showcases Medical-Grade TPU for Ureteral Stents at CMEF 2025

ICP DAS-BMP (Biomedical Polymers), a committed Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is excited to...

March 25, 2025 | Tuesday | News
AstraZeneca Announces $2.5 Billion Investment to Establish Sixth Global R&D Centre in Beijing

AstraZeneca announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manu...

March 24, 2025 | Monday | News
FDA Clears Altesa BioSciences' IND for Vapendavir to Treat Rhinovirus Infections in COPD Patients

Altesa BioSciences, Inc., a clinical-stage pharmaceutical company dedicated to developing new treatments for viral infections in vulnerable populations, an...

March 21, 2025 | Friday | News
Telix Pharmaceuticals' Illuccix® Receives Full ANVISA Approval for Prostate Cancer Imaging in Brazil

Telix Pharmaceuticals Limited announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or 'ANVISA') has approve...

March 19, 2025 | Wednesday | News
Sanofi Accelerates Flu Vaccine Production for 2025-26 Season, Aligning with FDA-Selected Strains

Sanofi announced the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing and ...

March 17, 2025 | Monday | News
Centivax Partners with Emery Pharma to Advance Potency Testing for Pan-Influenza Vaccine

Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration with ...

March 12, 2025 | Wednesday | News
Merck ( MSD ) Opens $1 Billion Vaccine Manufacturing Facility in Durham, North Carolina

Merck, known as MSD outside of the United States and Canada, announced  the opening of a new, $1 billion, 225,000-square-foot facility dedicated to va...

March 12, 2025 | Wednesday | News
Celltrion Wins FDA Approval for OMLYCLO®, First Interchangeable Biosimilar to XOLAIR®

Celltrion announced the U.S. Food and Drug Administration (FDA) approved OMLYCLO® (omalizumab-igec) as the first and only biosimila...

March 10, 2025 | Monday | News
CordenPharma Commits >€1 Billion to Expand Peptide Manufacturing Across Europe and the US

  CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and la...

March 05, 2025 | Wednesday | News
Enzene India Secures EU GMP Certification for Pune Facilities, Strengthening Global Biologics Manufacturing

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, today announced that its two facilities in Pune have received Europea...

March 05, 2025 | Wednesday | News
GHIT Fund Marks Milestone with First Administration of Arpraziquantel to Preschool Children in Uganda

The Global Health Innovative Technology (GHIT) Fund is announcing a significant milestone: the first administration of arpraziquantel to preschool-aged chi...

March 05, 2025 | Wednesday | News
Axplora Expands ADC Manufacturing Leadership with New Payload Facility in France

Axplora, a global leader in API small molecule and ADC (antibody-drug conjugate) manufacturing, is strengthening its leading position in the commercial m...

March 04, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close